GlassScriptPhysician profile
Ihab R Saab
NPI 1366874968
$5,368.12
in general payments reported to CMS, 2019-2025
14 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,982 · 2020: $655 · 2021: $237 · 2022: $264 · 2023: $1,774 · 2024: $297 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382 · Travel and Lodging: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.20 |
| Travel and Lodging | $848.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,868.44 | 2020-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Pinnacle, INC | $1,721.70 | 2019 | |
| Integra Lifesciences Corporation | $281.91 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $259.16 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $258.80 | 2022-2023 | |
| Polynovo North America LLC | $141.17 | 2024 | Novosorb Btm |
| Avita Medical Americas, LLC | $137.99 | 2025 | Cohealyx, Recell, Permeaderm |
| Allergan, INC. | $136.79 | 2019 | |
| Baxter Healthcare | $125.59 | 2021 | |
| Stryker Corporation | $125.02 | 2020 | |
| Depuy Synthes Sales INC. | $123.75 | 2023 | Trumatch |
| Bard Peripheral Vascular, INC. | $111.89 | 2021 | |
| Ethicon US, LLC | $54.99 | 2022 | |
| Mentor Worldwide LLC | $20.92 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ihab Saab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.